Granicip 1-DT Tablet

About

Granicip 1-DT Tablet contains Granisetron, a highly effective 5-HT3 receptor antagonist, specifically designed to prevent and treat nausea and vomiting. It acts by selectively blocking serotonin receptors located in the chemoreceptor trigger zone of the brain and on the vagal nerve terminals in the gastrointestinal tract. This targeted action prevents serotonin from binding to these receptors, thereby interrupting the signaling pathways that lead to the sensation of nausea and the act of vomiting.

The "DT" (Dispersible Tablet) formulation allows the tablet to be dissolved in a small amount of water before administration, making it easier to take for patients who have difficulty swallowing whole tablets, including children and the elderly. This ensures accurate dosing and facilitates rapid absorption, providing prompt and reliable relief from emetic symptoms, particularly those associated with chemotherapy, radiation therapy, and post-operative recovery.

Uses

• Prevention of nausea and vomiting induced by chemotherapy.
• Treatment of nausea and vomiting following radiation therapy.
• Prophylaxis against post-operative nausea and vomiting.
• Management of severe emesis from various medical conditions.

Directions For Use

Disperse the tablet in a small amount of water (e.g., 5-10 ml) and consume the solution immediately. Do not chew the tablet.

Benefits

• Effective in controlling chemotherapy-induced emesis.
• Dispersible formulation for easy administration.
• Rapid onset of action after dissolution.
• Reduces the incidence and severity of nausea.
• Improves patient comfort and quality of life.
• Well-tolerated with a targeted mechanism of action.

Side Effects

• Headache
• Constipation
• Diarrhea
• Dizziness
• Fatigue
• Insomnia
• Abdominal pain
• Fever
• Anxiety
• Rash
• Bradycardia
• Hypersensitivity reactions

Safety Measures

• Alcohol - Concurrent use of alcohol may increase the risk of central nervous system depression and gastrointestinal irritation. It is advisable to avoid alcohol.
• Pregnancy - This medication should be used during pregnancy only if the potential benefits outweigh the potential risks to the fetus. Consult your healthcare provider.
• Breastfeeding - It is not known whether Granisetron is excreted in human milk. Caution should be exercised when administering to a breastfeeding woman.
• Liver - Patients with severe hepatic impairment should be monitored closely, and dose adjustments may be considered by the treating physician.
• Kidney - No specific dose adjustment is generally necessary for patients with renal impairment, but clinical vigilance is recommended in severe cases.
• Lung - Granisetron is generally safe for individuals with lung conditions; no specific pulmonary precautions or contraindications are typically noted.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.